JEM Cancer Collection 2019

The advent of new lines of cancer research, ranging from basic in vivo tumor model to clinical research are included in this collection that celebrates the progress made to understand the biology of cancer, the interplay with immune system, and the development of highly innovative therapies.

Since its inception in 1896, the Journal of Experimental Medicine (JEM) has published on a broad array of disease-related topics, including cancer biology, tumor immunity and immunotherapy. In the last few years, we have made a concerted effort to reemphasize our interest in offering an attractive option for publishing high-quality cancer-related studies in a prestigious journal with broad visibility at JEM.

We hope you enjoy this collection, and we invite you to learn more about publishing in JEM.

About the artwork: Lee et al. report that metastatic tropism of ovarian cancer is actively orchestrated through the induction of neutrophil influx and chromatin extrusion in the premetastatic omental niche by early-stage tumors?see the associated article “Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum.” The image, which was featured as the cover of the January 2019 issue of JEM, illustrates the abundance of cells (blue) with neutrophil characteristic segmented morphology surrounding a vessel (red) in omental tissue of a woman with early-stage, high-grade serous carcinoma (HGSC). The image was provided by the authors and modified by the JEM editorial office.

We hope you appreciate this collection and encourage your comments on Twitter at @JExpMed. Interested in learning how we are making the publishing process easier for authors? Visit our Instructions for Authors or contact the Editorial office.